Vaccitech plc - ADR logo

VACC

Vaccitech plc - ADR

$5.09

Earnings Summary

Revenue
$15.02Mn
Net Profits
$2.6Mn
Net Profit Margins
17.29%

Highlights

Revenue:

Vaccitech plc - ADR’s revenue jumped 6885.12% since last year same period to $15.02Mn in the Q1 2022. On a quarterly growth basis, Vaccitech plc - ADR has generated 1501900% jump in its revenue since last 3-months.

Net Profits:

Vaccitech plc - ADR’s net profit jumped 117% since last year same period to $2.6Mn in the Q1 2022. On a quarterly growth basis, Vaccitech plc - ADR has generated 117.18% jump in its net profits since last 3-months.

Net Profit Margins:

Vaccitech plc - ADR’s net profit margin jumped 100.24% since last year same period to 17.29% in the Q1 2022. On a quarterly growth basis, Vaccitech plc - ADR has generated -100% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Vaccitech plc - ADR post its latest quarter earnings

EPS Estimate Current Quarter
-0.31
EPS Estimate Current Year
-0.31

Highlights

EPS Estimate Current Quarter:

Vaccitech plc - ADR’s earning per share (EPS) estimates for the current quarter stand at -0.31 - a 39.22% jump from last quarter’s estimates.

EPS Estimate Current Year:

Vaccitech plc - ADR’s earning per share (EPS) estimates for the current year stand at -0.31.

Key Ratios

Key ratios of the Vaccitech plc - ADR post its Q1 2022 earnings

Earning Per Share (EPS)
0.07
Return on Assets (ROA)
-0.16
Return on Equity (ROE)
-0.41
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Vaccitech plc - ADR’s earning per share (EPS) jumped 103.68% since last year same period to 0.07 in the Q1 2022. This indicates that the Vaccitech plc - ADR has generated 103.68% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Vaccitech plc - ADR’s return on assets (ROA) stands at -0.16.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Vaccitech plc - ADR’s return on equity (ROE) stands at -0.41.

Dividend Per Share (DPS):

Vaccitech plc - ADR declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-11
-0.31
0.07
122.58%

Company Information

Vaccitech is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. The company’s proprietary platform comprises proprietary modified simian adenoviral vectors, known as ChAdOx1 and ChAdOx2, as well as the well-validated Modified Vaccinia Ankara, or MVA, boost vector, both with demonstrable tolerability profiles and without the ability to replicate in humans. The combination of a ChAdOx prime treatment with subsequent MVA boost has consistently generated significantly higher magnitudes of CD8+ T cells compared with other technologies and approaches. The company has a broad pipeline of both clinical and preclinical stage therapeutic programs in solid tumors and viral infections and prophylactic viral vaccine programs. Vaccitech co-invented a COVID-19 vaccine with the University of Oxford, now approved for use in many territories and exclusively licensed worldwide to AstraZeneca through Oxford University Innovation, or OUI. Vaccitech is entitled to receive a share of the milestones and royalty income received by OUI from AstraZeneca.

Organisation
Vaccitech plc - ADR
Employees
2.02K